Sequrna AB
www.sequrna.com/Solna, Sweden
About
SEQURNA AB is a pioneering biotech startup spun out from Karolinska Institutet, specializing in synthetic thermostable RNase inhibitors for RNA-focused workflows. Our innovative technology simplifies RNA-sequencing and in situ sequencing processes, making them more accessible, cost-effective, and sustainable. Based in Stockholm and partnered with Nasdaq-Nordic-listed Genovis AB, SEQURNA is at the forefront of enabling next-generation RNA research and diagnostics worldwide.
Target market
UKUS BostonUS Wasington DC
Areas of activities
Biotechnology